Bioengineers, scientists, and researchers interested in genome editing and the game-changing prospects afforded by CRISPR-based systems will share the latest intelligence in the field at the 7th International Conference on CRISPR Technologies, taking place October 14–16, 2024, at the Bahia Resort Hotel in San Diego, California.
Organized by the Society for Biological Engineering (SBE) — a technical community of the American Institute of Chemical Engineers (AIChE) — the CRISPR conference unites the field’s innovators and thought leaders, who will deliver academic and commercial perspectives on CRISPR-based techniques, highlighting the potential of genome engineering for applications in biotechnology, agriculture, biomedicine, and other fields.
Conference presentations will be delivered by eminent people in the field, and include a keynote address by George Church, Professor of Genetics at Harvard Medical School and a Director of a U.S. Department of Energy Technology Center and a National Institutes of Health Center of Excellence in Genomic Science. Church developed the first methods for direct genome sequencing, molecular multiplexing, and barcoding — with his innovations contributing to nearly all “next generation” DNA sequencing methods. This, along with his work on chip-DNA-synthesis, gene editing, and stem cell engineering, have set the foundation for companies spanning medical diagnostics and synthetic biology.
Additional keynote speakers at the 2024 CRISPR Conference include Waseem Qasim, Professor of Cell and Gene Therapy at London’s Institute of Child Health; and Stanley Qi, Associate Professor in the Department of Bioengineering and the Department of Chemical and Systems Biology at Stanford University.
Over the past decade, CRISPR approaches— which involve cellular-level editing and manipulation of the genome — have permitted biotechnicians to modify DNA, genes, and the development of cells, with implications for medicine, agriculture, and other areas. Topics at the CRISPR conference cover the breadth of current research, and will be elaborated in sessions devoted to CRISPR biotechnology, genome editing tools (including artificial intelligence), commercial translation of gene editing, CRISPR-Cas biology, microbiome editing, safety in genome editing, clinical and biomedical applications of CRISPR, and more.
The International Conference on CRISPR Technologies is one event in a roster of SBE specialty conferences that cover topics pertinent to chemical and biochemical engineers in the biotechnology space. Complete program and registration information for the CRISPR Conference is available at www.aiche.org/CRISPR.
About AIChE: AIChE is a professional society of more than 60,000 members in more than 110 countries. Its members work in corporations, universities and government using their knowledge of chemical processes to develop safe and useful products for the benefit of society. Through its varied programs, AIChE continues to be a focal point for information exchange on the frontier of chemical engineering research in such areas as nanotechnology, sustainability, hydrogen fuels, biological and environmental engineering, and chemical plant safety and security. More information about AIChE is available at www.aiche.org.